A Study to Evaluate the, Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
AbbVie
AbbVie
AbbVie
AbbVie
Amgen
Kelonia Therapeutics, Inc.
Technische Universität Dresden
AbbVie
AbbVie
Altor BioScience
Taiho Oncology, Inc.
Pfizer
Kyowa Kirin Co., Ltd.
Anaveon AG
Celgene
Xencor, Inc.
AbbVie
Celularity Incorporated
GlaxoSmithKline
Celgene
Kartos Therapeutics, Inc.
Novartis
AbbVie
Novartis
Celgene
GlaxoSmithKline
GlaxoSmithKline
AbbVie
University of Iowa
University of Louisville
Leap Therapeutics, Inc.
Novartis
Bayer
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
H. Lee Moffitt Cancer Center and Research Institute
University of Arkansas
AVEO Pharmaceuticals, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
AstraZeneca
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
AstraZeneca
Facet Biotech